Skip to main content
LEMTRADA 12 mg/1.2mL injection, solution, concentrate by Genzyme Corporation
LEMTRADA, 12 mg/1.2mL, injection, solution, concentrate Drug class: CD52-directed Cytolytic Antibody. Available on prescription only. Listed by Genzyme Corporation.
Prescription only

LEMTRADA

ALEMTUZUMAB

Listed by Genzyme Corporation

Strength
12 mg/1.2mL
Form
Injection, Solution, Concentrate
Route
Intravenous
Class
CD52-directed Cytolytic Antibody

What it contains

  • Alemtuzumab 12 mg/1.2mL

FDA record

Dosage form Injection, Solution, Concentrate
Route Intravenous
Drug class CD52-directed Cytolytic Antibody
Approval route BLA — biologic licence
NDC code 58468-0200
FDA application BLA103948
RxNorm concept 1594658
Package sizes listed 1
Marketed since November 2014

Other products containing Alemtuzumab

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Campath

ALEMTUZUMAB

Strength
30 mg/mL
Form
Injection
Class
CD52-directed Cytolytic Antibody
Rx only

Genzyme Corporation

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.